☆ 4.6 Letter

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment

JAMA ONCOLOGY (2022)

Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy

Carlo Aschele et al.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Hematology

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Yair Herishanu et al.

Summary: Patients with chronic lymphocytic leukemia have a significantly impaired antibody response to the BNT162b2 mRNA COVID-19 vaccine, which is influenced by disease activity and treatment.

BLOOD (2021)

添加到收藏夹

Article Oncology

Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment

A. Grinshpun et al.

Summary: The immunologic response to COVID-19 and/or the BNT162b2 mRNA COVID-19 vaccine among cancer patients on active treatment was evaluated, and it was found that chemotherapy patients had significantly reduced humoral response to infection or vaccination. These findings suggest the need for close monitoring and consideration for booster vaccine prioritization in cancer patients under chemotherapy.

ESMO OPEN (2021)

添加到收藏夹

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

Yinon M. Bar-On et al.

Summary: After receiving a third dose of the BNT162b2 mRNA vaccine, Israeli residents aged 60 and above who had previously received two doses of the vaccine saw significantly lower rates of confirmed Covid-19 infection and severe illness compared to those who did not receive a booster shot, indicating the effectiveness of the booster dose in reducing infection and severe illness.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Oncology

COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study

Gagandeep Brar et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment

相关参考文献

Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel

COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study

导出引文

分享论文